Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cipla Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Cipla Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cipla Ltd (CIPLA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

18 May 2016 Thomson Reuters Stock Report 11 $25.00

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review Summary Cipla Ltd. (Cipla) is a global pharmaceutical compa...

10 May 2016 GlobalData 109 $300.00

Company Snapshot - Cipla

Two Directors at Cipla sold 4,664 shares at 0.000INR. The significance rating of the trade was 67/100. Is that information s...

03 May 2016 Directors Deals Ltd. 1 $12.00

Wright Investors Service Comprehensive Report for Cipla Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Apr 2016 Wright Reports 56 $75.00

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review Summary Cipla Ltd. (Cipla) is a global pharmaceutical compa...

02 Mar 2016 GlobalData 121 $300.00

MOSL: CIPLA 3QFY16 (Neutral)-Weak results-Margin recovery is key

CIPLA 3QFY16: Weak results; Margin recovery is key (CIPLA IN, Mkt Cap USD6.5b, CMP INR534, TP INR600, 12% Upside, Neutral) ...

15 Feb 2016 Motilal Oswal Securities Ltd. 10 $104.00

KRChoksey |Institutional | Cipla Ltd. Q3FY16 Result Update - "BUY"

“Muted quarter; outlook remains robust” Result highlights Cipla’s Q3FY16 Net Sales, EBITDA and PAT were below our estimates. ...

12 Feb 2016 Kisan Ratilal Choksey Shares and Securities Private Limited 7 $69.00

Cipla Ltd_Q3FY16 Result Updates

Cipla Ltd Changes in domestic formulation business and higher R&D spend impacts earnings Cipla’s adjusted PAT for 3QFY16 ...

11 Feb 2016 IndiaNivesh Securities Pvt Ltd 5 $46.00